Anti-amyloid-β immunotherapy in alzheimer's disease: Acc-001 clinical trials are ongoing

Journal of Alzheimer's Disease

Volumn 17, Issue 2, 2009, Pages 243-

  Ryan, J Michael ^a   Grundman, Michael ^b  

^a PFIZER INC   (United States)

^b ELAN PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY;

ALZHEIMER DISEASE; CLINICAL TRIAL; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; PRIORITY JOURNAL;

EID: 67849102202     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1118     Document Type: Letter

References (1)

1. Wilcock DM, Colton CA (2008) Anti-amyloid-β immunother- apy in Alzheimer's disease: relevance of transgenic mouse studies to clinical trials. J Alzheimers Dis 15, 555-569.